Curevo Vaccine Announces Positive Topline Results from
-- Positive data from 876-patient head-to-head trial versus Shingrix® shows amezosvatein met the primary immunogenicity endpoint, eliciting a robust immune...
Source: globenewswire.com
Stay updated with breaking news from Like Shingrix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Positive data from 876-patient head-to-head trial versus Shingrix® shows amezosvatein met the primary immunogenicity endpoint, eliciting a robust immune...